About
Crispr Therapeutics Ag (NASDAQ:CRSP) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 20 2026
Arrayed CRISPR Screening Market Presents Lucrative Opportunities Through 2026-2030: Total Revenue to Grow by $1.64 Billion at 17.7% CAGR
Apr 7 2026
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar 11 2026
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Mar 10 2026
CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering
Feb 12 2026
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Financials
Revenue
$3.51 M
Market Cap
$4.75 B
EPS
-6.47
Translate